Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
Frequently Asked Questions
What is Market Cap of Realm Therapeutics plc - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Realm Therapeutics plc - ADR market cap is N/A.
What is the 52-week high for Realm Therapeutics plc - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Realm Therapeutics plc - ADR 52 week high is N/A as of September 11, 2025.
What is the 52-week low for Realm Therapeutics plc - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Realm Therapeutics plc - ADR 52 week low is N/A as of September 11, 2025.
What was Realm Therapeutics plc - ADR stock price yesterday?
Realm Therapeutics plc - ADR stock price yesterday was $2.51.
What is the PE ratio of Realm Therapeutics plc - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Realm Therapeutics plc - ADR’s P/E ratio is None.
What is the Price-to-Book ratio of Realm Therapeutics plc - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Realm Therapeutics plc - ADR P/B ratio is None.
What is Realm Therapeutics plc - ADR's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Realm Therapeutics plc - ADR's EBITDA is 0.78.
What is the 50-day moving average of Realm Therapeutics plc - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Realm Therapeutics plc - ADR 50-day moving average is N/A.
How many employess does Realm Therapeutics plc - ADR has?